NO743815L - - Google Patents

Info

Publication number
NO743815L
NO743815L NO743815A NO743815A NO743815L NO 743815 L NO743815 L NO 743815L NO 743815 A NO743815 A NO 743815A NO 743815 A NO743815 A NO 743815A NO 743815 L NO743815 L NO 743815L
Authority
NO
Norway
Prior art keywords
compound
physiologically acceptable
acid addition
compound according
acceptable acid
Prior art date
Application number
NO743815A
Other languages
English (en)
Norwegian (no)
Inventor
R L Brattsand
K G Claeson
S I Gustavsson
H G Oresten
L-I Wickstroem
Original Assignee
Astra Bofors Nobelpharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Bofors Nobelpharma Ab filed Critical Astra Bofors Nobelpharma Ab
Publication of NO743815L publication Critical patent/NO743815L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO743815A 1973-10-24 1974-10-23 NO743815L (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7314402A SE377691B (cs) 1973-10-24 1973-10-24

Publications (1)

Publication Number Publication Date
NO743815L true NO743815L (cs) 1975-05-20

Family

ID=20318905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO743815A NO743815L (cs) 1973-10-24 1974-10-23

Country Status (11)

Country Link
JP (1) JPS5070372A (cs)
AU (1) AU7451674A (cs)
BE (1) BE821410A (cs)
DE (1) DE2448036A1 (cs)
DK (1) DK553974A (cs)
FI (1) FI309274A (cs)
FR (1) FR2248847A1 (cs)
LU (1) LU71169A1 (cs)
NL (1) NL7413950A (cs)
NO (1) NO743815L (cs)
SE (1) SE377691B (cs)

Also Published As

Publication number Publication date
DE2448036A1 (de) 1975-05-15
JPS5070372A (cs) 1975-06-11
FR2248847A1 (en) 1975-05-23
LU71169A1 (cs) 1975-06-24
BE821410A (fr) 1975-04-24
SE7314402A (cs) 1975-04-25
FI309274A (cs) 1975-04-25
DK553974A (cs) 1975-06-16
AU7451674A (en) 1976-04-29
NL7413950A (nl) 1975-04-28
SE377691B (cs) 1975-07-21

Similar Documents

Publication Publication Date Title
US3239417A (en) Methods and compositions for inhibiting sterol biosynthesis
BG60837B2 (bg) Соли на омепразола
US5190947A (en) Codeine salt of a substituted carboxylic acid, its use and pharmaceutical compositions thereof
EP3680232A1 (en) NOVEL ANTHRANILIC ACID-BASED COMPOUND, AND Pin1 INHIBITOR, THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES AND THERAPEUTIC AGENT FOR CANCER THAT USE THE SAME
KR100437307B1 (ko) 토라세미드의 새로운 결정 변형태 ⅲ
CN102010298A (zh) 作为药物活性剂的茚衍生物
EP3679930A1 (en) Therapeutic agent for fatty liver diseases and therapeutic agent for adiposity
CS207773B2 (en) Method of making the new substituted 2-phenyl-iminoimidazolines
SE466683B (sv) Spiroketalsteroidglykosider och/eller estrar daerav till anvaendning som laekemedel
NZ209330A (en) Oxybenzene derivatives and pharmaceutical compositions
IL34238A (en) Morpholinyl ethers and process for their preparation
NO743815L (cs)
NZ204589A (en) 3-(n,n-dimethylcarbamoyl)-pyrazolo(1,5-a)pyridine and pharmaceutical compositions
SK10622002A3 (sk) Étery dikarboxylátu vápenatého, metódy ich výroby a ich využitie na liečbu vaskulárnych chorôb a diabetu
US4260767A (en) 2-Pyridylhydrazides
EP0228314A2 (en) Use of ethanol/amine derivatives in treating or preventing hyperlipemia
US4464379A (en) Indol acetic acid derivatives and anti-inflamatory and related uses thereof
EP0047358B1 (en) Indol acetic derivatives, process for producing the same and pharmaceutical compositions comprising the same
US4358441A (en) Nicotinic derivatives of glucosamine and related pharmaceutical compositions
US3322771A (en) Intermediates for preparing thebaine derivatives
JPH053474B2 (cs)
SU1074876A1 (ru) @ -Четвертичные производные 10-бромсандвицина или 10-бромизосандвицина,обладающие антиаритмическими свойствами
NO750733L (cs)
US4187311A (en) 3-Aryloxy-1-carboalkoxyethylpyridinium compounds and compositions
US4614743A (en) Methods of treating pain and inflammation with 4,7-dimethyl-2-(4-pyridinyl)-1,2,4,-triazolo[1,5-a]pyrimidin-5(4H)-one or the pharmaceutically acceptable salts or solvates thereof